These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 36262511)

  • 1. EUS-guided radiofrequency ablation of pancreatic/peripancreatic tumors and oligometastatic disease: an observational prospective multicenter study.
    Figueiredo Ferreira M; Garces-Duran R; Eisendrath P; Devière J; Deprez P; Monino L; Van Laethem JL; Borbath I
    Endosc Int Open; 2022 Oct; 10(10):E1380-E1385. PubMed ID: 36262511
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic insulinoma: A single-center experience.
    Borrelli de Andreis F; Boškoski I; Mascagni P; Schepis T; Bianchi A; Schinzari G; Annicchiarico BE; Quero G; Tortora G; Alfieri S; Gasbarrini A; Costamagna G; Spada C; Attili F
    Pancreatology; 2023 Aug; 23(5):543-549. PubMed ID: 37236853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic Ultrasound-guided Radiofrequency Ablation Versus Surgical Resection for Treatment of Pancreatic Insulinoma.
    Crinò SF; Napoleon B; Facciorusso A; Lakhtakia S; Borbath I; Caillol F; Do-Cong Pham K; Rizzatti G; Forti E; Palazzo L; Belle A; Vilmann P; van Laethem JL; Mohamadnejad M; Godat S; Hindryckx P; Benson A; Tacelli M; De Nucci G; Binda C; Kovacevic B; Jacob H; Partelli S; Falconi M; Salvia R; Landoni L; ; Larghi A
    Clin Gastroenterol Hepatol; 2023 Oct; 21(11):2834-2843.e2. PubMed ID: 36871765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of endoscopic ultrasound-guided radiofrequency ablation for management of pancreatic lesions: a systematic review and meta-analysis.
    Fahmawi Y; Mehta A; Abdalhadi H; Merritt L; Mizrahi M
    Transl Gastroenterol Hepatol; 2022; 7():30. PubMed ID: 35892058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EUS-guided radiofrequency ablation for pancreatic insulinoma: experience in 2 tertiary centers.
    Marx M; Trosic-Ivanisevic T; Caillol F; Demartines N; Schoepfer A; Pesenti C; Ratone JP; Robert M; Giovannini M; Godat S
    Gastrointest Endosc; 2022 Jun; 95(6):1256-1263. PubMed ID: 34902374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic ultrasound-guided ethanol and radiofrequency ablation of pancreatic insulinomas: a systematic literature review.
    El Sayed G; Frim L; Franklin J; McCrudden R; Gordon C; Al-Shamma S; Kiss S; Hegyi P; Erőss B; Hegyi PJ
    Therap Adv Gastroenterol; 2021; 14():17562848211042171. PubMed ID: 34819995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic ultrasound-guided radiofrequency ablation: An effective and safe alternative for the treatment of benign insulinoma.
    Furnica RM; Deprez P; Maiter D; Vandeleene B; Borbath I
    Ann Endocrinol (Paris); 2020 Dec; 81(6):567-571. PubMed ID: 33285105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EUS-guided Radiofrequency Ablation (EUS-RFA) of Solid Pancreatic Neoplasm Using an 18-gauge Needle Electrode: Feasibility, Safety, and Technical Success.
    Crinò SF; D'Onofrio M; Bernardoni L; Frulloni L; Iannelli M; Malleo G; Paiella S; Larghi A; Gabbrielli A
    J Gastrointestin Liver Dis; 2018 Mar; 27(1):67-72. PubMed ID: 29557417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technique, safety, and feasibility of EUS-guided radiofrequency ablation in unresectable pancreatic cancer.
    Scopelliti F; Pea A; Conigliaro R; Butturini G; Frigerio I; Regi P; Giardino A; Bertani H; Paini M; Pederzoli P; Girelli R
    Surg Endosc; 2018 Sep; 32(9):4022-4028. PubMed ID: 29766302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study protocol for a multicenter randomized controlled trial to compare radiofrequency ablation with surgical resection for treatment of pancreatic insulinoma.
    Crinò SF; Partelli S; Napoleon B; Conti Bellocchi MC; Facciorusso A; Salvia R; Forti E; Cintolo M; Mazzola M; Ferrari G; Carrara S; Repici A; Zerbi A; Lania A; Tacelli M; Arcidiacono PG; Falconi M; Larghi A; Rizzatti G; Alfieri S; Panzuto F; Hindryckx P; Berrevoet F; Lapauw B; Lakhtakia S; Sundaram S; Samanta J; Rastogi A; Landoni L
    Dig Liver Dis; 2023 Sep; 55(9):1187-1193. PubMed ID: 37407318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoscopic ultrasound-guided radiofrequency ablation of premalignant pancreatic-cystic neoplasms and neuroendocrine tumors: prospective study.
    Younis F; Ben-Ami Shor D; Lubezky N; Geva R; Osher E; Shibolet O; Phillips A; Scapa E
    Eur J Gastroenterol Hepatol; 2022 Nov; 34(11):1111-1115. PubMed ID: 36170679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EUS-guided radiofrequency ablation for management of pancreatic insulinoma by using a novel needle electrode (with videos).
    Lakhtakia S; Ramchandani M; Galasso D; Gupta R; Venugopal S; Kalpala R; Reddy DN
    Gastrointest Endosc; 2016 Jan; 83(1):234-9. PubMed ID: 26394384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic ultrasound-guided radiofrequency ablation for management of benign solid pancreatic tumors.
    Choi JH; Seo DW; Song TJ; Park DH; Lee SS; Lee SK; Kim MH
    Endoscopy; 2018 Nov; 50(11):1099-1104. PubMed ID: 29727904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanded indication for EUS-guided radiofrequency ablation: management of adrenal tumors.
    Cho SH; Kim DH; Seo DW; Yoo SK; Oh D; Song TJ; Lee SK
    Gastrointest Endosc; 2023 Nov; 98(5):790-796. PubMed ID: 37356635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing EUS-guided radiofrequency ablation in unresectable pancreatic ductal adenocarcinoma: a single-center historic cohort study.
    Robles-Medranda C; Del Valle R; Puga-Tejada M; Arevalo-Mora M; Cunto D; Egas-Izquierdo M; Estrada-Guevara L; Bunces-Orellana O; Moreno-Zambrano D; Alcivar-Vasquez J; Alvarado-Escobar H; Merfea RC; Barreto-Perez J; Rodriguez J; Calle-Loffredo D; Pitanga-Lukashok H; Baquerizo-Burgos J; Tabacelia D
    Gastrointest Endosc; 2024 Aug; 100(2):250-258. PubMed ID: 38518978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic ultrasound-guided radiofrequency ablation of pancreatic neuroendocrine tumors: a case series.
    de Nucci G; Imperatore N; Mandelli ED; di Nuovo F; d'Urbano C; Manes G
    Endosc Int Open; 2020 Dec; 8(12):E1754-E1758. PubMed ID: 33269307
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of non-functional pancreatic neuroendocrine tumors by endoscopic ultrasound-guided radiofrequency ablation: Retrospective study in two tertiary centers.
    Marx M; Godat S; Caillol F; Poizat F; Ratone JP; Pesenti C; Schoepfer A; Hoibian S; Dahel Y; Giovannini M
    Dig Endosc; 2022 Sep; 34(6):1207-1213. PubMed ID: 34963025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes of EUS-guided radiofrequency ablation for unresectable pancreatic cancer: A prospective observational study.
    Oh D; Seo DW; Song TJ; Park DH; Lee SK; Kim MH
    Endosc Ultrasound; 2022; 11(1):68-74. PubMed ID: 35083978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic ultrasound radiofrequency ablation of pancreatic insulinoma in elderly patients: Three case reports.
    Rossi G; Petrone MC; Capurso G; Partelli S; Falconi M; Arcidiacono PG
    World J Clin Cases; 2022 Jul; 10(19):6514-6519. PubMed ID: 35979317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) for advanced pancreatic and periampullary adenocarcinoma.
    Thosani N; Cen P; Rowe J; Guha S; Bailey-Lundberg JM; Bhakta D; Patil P; Wray CJ
    Sci Rep; 2022 Oct; 12(1):16516. PubMed ID: 36192558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.